Skip to main content
Clinical Trials/NCT02442102
NCT02442102TerminatedNot Applicable

Understanding and Improving Dysphagia After Mechanical Ventilation

Johns Hopkins University1 site in 1 country58 target enrollmentStarted: July 1, 2015Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Terminated
Enrollment
58
Locations
1
Primary Endpoint
Number of participants aspirating during fiberoptic endoscopic swallow study

Study Overview

Brief Summary

An early intervention for swallowing disorders (i.e., dysphagia) during endotracheal intubation may improve patient outcomes. The investigators propose treatment sessions targeting sensorimotor integration, strength, and range of motion during oral endotracheal intubation with mechanical ventilation to reduce or prevent dysphagia and aspiration (food or liquids entering the airway), establish a solid foundation in understanding reasons for swallowing impairment after extubation from mechanical ventilation and learn new methods to reduce or prevent these problems.

Detailed Description

The overall goals of this study are to evaluate patients with acute respiratory failure from the time they are orally intubated in the ICU to: 1) investigate tongue weakness and other pathophysiological aspects of dysphagia, and 2) evaluate, in a Phase II clinical trial, a novel, multimodal, sensorimotor intervention conducted during intubation to reduce or prevent dysphagia after extubation. Patients who are expected to be intubated with mechanical ventilation for >96 hours will be consecutively enrolled shortly after intubation. Laryngeal function, tongue strength, swallowing pathophysiology, and breathing-swallowing coordination will be evaluated with valid and reliable standardized measures. While orally intubated, patients in the treatment group will receive a novel, early, sensorimotor intervention for 60-minutes daily, 5 times per week, targeting improved swallowing physiology and kinematics to reduce aspiration and dysphagia. These daily sessions will continue until the completion of a modified barium swallow study conducted within approximately 2 days after extubation, and thereafter standard clinical care will resume. Patients in the control group will receive standard clinical care during intubation and throughout their hospital stay. All patients will be followed to hospital discharge to determine the pathophysiological and clinical impact of the proposed intervention. Knowledge from this study will provide important data for this novel intervention and provide a critical foundation for understanding the physiological mechanisms of dysphagia and aspiration after intubation in patients with acute respiratory failure. With success, this investigation will help shift clinical practice patterns to consider early intervention with the goal of reducing the frequency and severity of swallowing impairment leading to aspiration and additional medical complications.

Study Design

Study Type
Interventional
Allocation
Na
Intervention Model
Single Group
Primary Purpose
Treatment
Masking
None

Eligibility Criteria

Ages
18 Years to 100 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •≥18 years old
  • •Required mechanical ventilation via an oral endotracheal tube

Exclusion Criteria

  • •Unable to understand or speak English due to a language barrier
  • •Unable to understand or speak English due to a cognitive impairment
  • •Barium sulfate allergy
  • •Pregnancy
  • •Presence of any cardiac pacing device (including temporary epicardial pacing) without an underlying cardiac rhythm as confirmed by treating physician or diaphragmatic pacer
  • •Nasal endotracheal intubation during the present admission
  • •Patient is not expected to require ≥48 hours of intubation
  • •Pre-existing dysphagia/aspiration, voice or cognitive disorder
  • •Reflux with history of known or suspected aspiration
  • •Presence of a central nervous system, neuromuscular or connective tissue disease (e.g., stroke, Guillain-Barre, scleroderma)
  • •Active seizure disorder
  • •Pain disorder of the jaw muscles or mandibular joint
  • •Ever tracheotomy or prior endotracheal intubation other than for surgery (≤ 1 year)
  • •Head and/or neck disease (e.g., oropharyngeal cancer)
  • •Head and/or neck surgery other than tonsillectomy
  • •Known or suspected anatomical abnormalities or pre-intubation trauma of the oral cavity, pharynx, larynx, or esophagus
  • •Known or suspected sleep apnea (treated or untreated)
  • •Prior major thoracic surgery (e.g., sternotomy, thoracotomy)
  • •Unplanned (e.g., self- or accidental) extubation or re-intubation before consent
  • •Weight exceeds capacity of the radiology equipment
  • •Expected tracheostomy tube placement while in hospital
  • •Moribund (>90% probability of mortality in hospital), based on ICU team's assessment

Arms & Interventions

Exercise and sensory stimulation

Experimental

60-minute sessions with sensory electrical stimulation (SES) applied 5 days per week with oromotor exercises completed when patient is able to participate

Intervention: Exercise and sensory stimulation (Behavioral)

Outcomes

Primary Outcomes

Number of participants aspirating during fiberoptic endoscopic swallow study

Time Frame: participants will be evaluated an expected average of 48 hours after extubation

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (1)

Loading locations...

Similar Trials